OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Celastrol targeting Nedd4 reduces Nrf2-mediated oxidative stress in astrocytes after ischemic stroke
Zexuan Hong, Jun Cao, Dandan Liu, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 2, pp. 156-169
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Nature’s magic: how natural products work hand in hand with mitochondria to treat stroke
Lin Cheng, Shangbin Lv, Wei Chen, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1

The role of celastrol in inflammation and diseases
Lei Han, Yantian Ruan, Ruidong Ding, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access | Times Cited: 1

Plant-Based Antioxidants for Prevention and Treatment of Neurodegenerative Diseases: Phytotherapeutic Potential of Laurus nobilis, Aronia melanocarpa, and Celastrol
Kristina Pilipović, Renata Jurišić Grubešić, Petra Dolenec, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 746-746
Open Access | Times Cited: 20

The potential of herbal drugs to treat heart failure: The roles of Sirt1/AMPK
Tao Zhang, Lei Xu, Xiaowei Guo, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 14, Iss. 2, pp. 157-176
Open Access | Times Cited: 18

Celastrol functions as an emerging manager of lipid metabolism: Mechanism and therapeutic potential
Jia Gu, Yaning Shi, Neng Zhu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114981-114981
Open Access | Times Cited: 14

A novel marine-derived anti-acute kidney injury agent targeting peroxiredoxin 1 and its nanodelivery strategy based on ADME optimization
Ping Yu, Tanwei Gu, Yueyang Rao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3232-3250
Open Access | Times Cited: 4

The Role and Mechanisms of Ubiquitin-Proteasome System-Mediated Ferroptosis in Neurological Disorders
Xin Liu, Wei Wang, Qunhua Nie, et al.
Neuroscience Bulletin (2025)
Closed Access

Research progress of small-molecule natural medicines for the treatment of ischemic stroke
Kui Liu, Ling Wang, Tao Pang
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 1, pp. 21-30
Closed Access

Subtype-selective effect and molecular regulation of celastrol and triptolide at human nicotinic acetylcholine receptors
Myungmi Moon, Minsu Pyeon, Jianfeng Yang, et al.
Chemico-Biological Interactions (2025), pp. 111412-111412
Closed Access

Regulation of Postoperative Cognitive Dysfunction by Glutathione Under Various Pathways: A Narrative Review
Yan He, Ying Zhang, Qing Liu
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access

Astrocyte modulation in cerebral ischemia-reperfusion injury: A promising therapeutic strategy
Ziyu Wang, Xiaolu Zhang, Guangming Zhang, et al.
Experimental Neurology (2024) Vol. 378, pp. 114814-114814
Closed Access | Times Cited: 3

Self-delivery of a metal-coordinated anti-angiogenic nanodrug with GSH depleting ability for synergistic chemo-phototherapy
Fukai Zhu, Cailin Huang, Yanling Lin, et al.
Biomaterials Science (2023) Vol. 11, Iss. 21, pp. 7132-7145
Closed Access | Times Cited: 7

Astrocytes in stroke-induced neurodegeneration: a timeline
Eileen Collyer, Elena Blanco‐Suárez
Frontiers in Molecular Medicine (2023) Vol. 3
Open Access | Times Cited: 7

Celastrol enhances the viability of random‐pattern skin flaps by regulating autophagy through the AMPK‐mTOR‐TFEB axis
Mingbao Gu, Chenchao Li, Qingyu Deng, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 3020-3036
Closed Access | Times Cited: 2

Tongqiao Huoxue Decoction inhibits ferroptosis by facilitating ACSL4 ubiquitination degradation for neuroprotection against cerebral ischemia-reperfusion injury
Zhijie Ou, Yanting Deng, Yan Wu, et al.
Phytomedicine (2024) Vol. 130, pp. 155701-155701
Closed Access | Times Cited: 2

Ferroptosis: a new target for hepatic ischemia-reperfusion injury?
Shanshan Guo, Zexin Li, Yi Liu, et al.
Free Radical Research (2024) Vol. 58, Iss. 6-7, pp. 396-416
Closed Access | Times Cited: 2

Neuroprotection of celastrol against postoperative cognitive dysfunction through dampening cGAS-STING signaling
Xueshan Bu, Hui Guo, Wenwei Gao, et al.
Experimental Neurology (2024) Vol. 382, pp. 114987-114987
Closed Access | Times Cited: 2

Druggability, molecular targets, and nanocarrier delivery of natural triterpenoid celastrol against chronic diseases
Chi Lui Chan, Yilu Sun, Xiaowen Mao, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 2

NEDD4L mediates intestinal epithelial cell ferroptosis to restrict inflammatory bowel diseases and colorectal tumorigenesis
Jingjing Liang, Ning Wang, Yihan Yao, et al.
Journal of Clinical Investigation (2024) Vol. 135, Iss. 3
Open Access | Times Cited: 2

Proteolysis Targeting Chimeras (PROTACs) based on celastrol induce multiple protein degradation for triple-negative breast cancer treatment
Xuelan Gan, Handong Wang, Jianguo Luo, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 192, pp. 106624-106624
Open Access | Times Cited: 6

Targeted liposomes for macrophages-mediated pulmonary fibrosis therapy
Yujie Wang, Fang Zhao, Xiangyu Wang, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 9, pp. 2356-2369
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top